Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Ebanga for the treatment of Zaire ebolavirus

Dec. 23, 2020

Phase III DOM-INNATE trial of SGX-942 does not show statistically significant benefit

Dec. 23, 2020

Positive topline data from pivotal phase III study of setmelanotide in BBS and Alstrom syndrome

Dec. 23, 2020

Mouse model of malformations of cortical development and epilepsy

Dec. 23, 2020

Initial phase I data presented for BFCR-4350A in relapsed/refractory multiple myeloma

Dec. 23, 2020

Phase II study of AZR-MD-001 for contact lens discomfort meets primary endpoints

Dec. 22, 2020

Topline ACCOLADE data for avacopan in C3 glomerulopathy

Dec. 22, 2020

Polyphor cleared to begin phase I study of inhaled murepavadin

Dec. 22, 2020

European Commission approves cabotegravir and rilpivirine long-acting injectable for HIV

Dec. 22, 2020

OSE initiates phase II trial of OSE-127 in ulcerative colitis

Dec. 22, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...